Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$4.11 0.22 (5.66%) as of 4:30 Thu 3/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 252.35(M)
Last Volume: 1,371,485 Avg Vol: 628,447
52 Week Range: $3.38 - $6.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  803
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 121,098 121,098 148,134 388,157
Total Sell Value $513,345 $513,345 $684,141 $2,735,436
Total People Sold 5 5 6 8
Total Sell Transactions 10 10 14 33
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 549
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2024-03-05 4 S $4.21 $38,830 D/D (9,229) 129,789 6%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2024-03-05 4 S $4.20 $37,411 D/D (8,902) 231,014 6%     
   Birznieks Gunther SVP, Business Development   •       –      –    2024-03-05 4 S $4.13 $35,884 D/D (8,684) 313,569 6%     
   Williams Timothy SVP & General Counsel   •       –      –    2024-03-05 4 S $4.18 $37,396 D/D (8,941) 196,825 6%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2024-03-05 4 S $4.13 $100,273 D/D (24,288) 1,871,730 6%     
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2024-03-04 4 S $4.41 $33,091 D/D (7,498) 139,018 9%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2024-03-04 4 S $4.48 $25,982 D/D (5,798) 239,916 9%     
   Birznieks Gunther SVP, Business Development   •       –      –    2024-03-04 4 S $4.30 $37,495 D/D (8,727) 322,253 9%     
   Williams Timothy SVP & General Counsel   •       –      –    2024-03-04 4 S $4.41 $35,917 D/D (8,147) 205,766 9%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2024-03-04 4 S $4.24 $131,066 D/D (30,884) 1,896,018 9%     
   Williams Timothy SVP & General Counsel   •       –      –    2024-02-16 4 A $0.00 $0 D/D 125,000 213,913     -
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2024-02-16 4 A $0.00 $0 D/D 32,700 146,516     -
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2024-02-16 4 A $0.00 $0 D/D 125,000 245,714     -
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2024-02-16 4 A $0.00 $0 D/D 450,000 1,926,902     -
   Birznieks Gunther SVP, Business Development   •       –      –    2024-02-16 4 A $0.00 $0 D/D 125,000 330,980     -
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2023-08-21 4 S $5.84 $21,748 D/D (3,724) 113,816 28%     
   Mitchell Stephen Ray Director   –       •      –    2023-08-10 4 S $6.05 $39,349 D/D (6,500) 29,328 36%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2023-07-28 4 S $6.30 $13,945 D/D (2,212) 120,714 33%     
   Williams Timothy SVP & General Counsel   •       –      –    2023-06-13 4 S $6.56 $95,754 D/D (14,600) 88,913 34%     
   Honore Tage Director   –       •      –    2023-06-08 4 A $0.00 $0 D/D 17,307 43,715     -
   Dugan Richard W Director   –       •      –    2023-06-08 4 A $0.00 $0 D/D 17,307 97,700     -
   Chrousos Phaedra Director   –       •      –    2023-06-08 4 A $0.00 $0 D/D 17,307 42,238     -
   Ward Anne Sempowski Director   –       •      –    2023-06-08 4 A $0.00 $0 D/D 17,307 39,313     -
   Mitchell Stephen Ray Director   –       •      –    2023-06-08 4 A $0.00 $0 D/D 17,307 35,828     -
   Honore Tage Director   –       •      –    2023-03-15 4 A $0.00 $0 D/D 26,408 26,408     -

  549 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed